Akari Therapeutics Plc. (NASDAQ: AKTX) Announces $12 Million Private Placement Offering and Releases Q1 2021 Results

July 9, 2021

Akari Therapeutics Plc. (NASDAQ: AKTX) has entered a definitive securities purchase agreement with some accredited institutional investors led by current shareholders, including Ray Prudo, the company’s chairman. The private placement of the equity securities will generate gross proceeds of around $12 million.  Akari to offer ADS at $1.55 per share in a private placement The company will offer unregistered American Depository Shares at $1.55 per ADS, in accordance with the…

Read More >>